Biologics

Biofirma, a subsidiary of IMAC Holdings, received "registered" status by the FDA.

A study published in Stem Cells Translational Medicine found that an injection of human amniotic fluid stem cells can be used to protect the spinal cord of a fetus from myelomeningocele.

John Tierney, DO, used Anika Therapeutics' injectable hyaluronic acid-based bone repair product in a patient.

Bioventus plans to expand Durolane, its hyaluronic acid joint-fluid osteoarthritis injection, into Australia and New Zealand.

Daniel Penello, MD, of Alexander Orthopaedic Associates in St. Petersburg, Fla., is a fellowship-trained orthopedic surgeon who specializes in hand and upper extremity surgery.

A group of orthobiologics experts established a Delphi panel process to set treatment standards for an outpatient stem cell procedure known as bone marrow concentrate.

PTC Therapeutics is leasing a 185,000-square-foot biologics-focused research space from Bristol-Myers Squibb, BioPharmaReport.com reports.

The California Institute for Regenerative Medicine has been instrumental in stem cell research since it was first established in 2004, but it faces closure in 2022 if a ballot initiative to get it more funding is unsuccessful. 

Discgenics treated the first patients in its clinical trial of intervertebral disc tissue for mild to moderate degenerative disc disease in Japan, reports Biospectrum Asia.

Andreas Gomoll, MD, implanted Cartiheal's Agili-C in two patients in an investigational device exemption study at Hospital for Special Surgery in New York City.